Omeprazole, marketed as Prilosec, is a widely used proton pump inhibitor (PPI) in America, taken by approximately 20 million individuals to reduce stomach acid. While trusted for over three decades to treat conditions like frequent heartburn, gastroesophageal reflux disease (GERD), stomach ulcers, and erosive esophagitis, new scientific findings suggest that this popular medication could be depleting the body of vital minerals when used long-term.

PPIs like omeprazole are designed for short-term use, typically four to eight-week courses. However, millions of users take them indefinitely, potentially compounding the associated risks. Scientists at the Federal University of São Paulo in Brazil conducted a study using rats, administering a standard human-equivalent dose of omeprazole daily for periods of 10, 30, and 60 days. This dosing strategy aimed to model human short-term prescription use at its upper limit.

The comprehensive analysis, published in the journal ACS Omega, revealed a cascade of health problems in the rats, beginning with blood markers consistent with early anemia, or iron deficiency. The study showed a significant disruption in how their bodies stored essential minerals. Specifically, copper levels in the liver plummeted, a critical issue because copper is required for the absorption of iron from food. Simultaneously, iron accumulated abnormally in organs like the liver and spleen instead of circulating in the blood for red blood cell production.

Over the 60-day period, rats receiving omeprazole showed steadily dropping iron levels, ending up markedly lower (180.23 µg/dL) compared to the control group (215.1 µg/dL), directly indicating reduced circulating iron. Hemoglobin levels in the omeprazole group also fell steadily, dropping below control levels by day 30 and continuing to decline. This combination crippled red blood cell production, leading to signs of developing anemia with declining red blood cell counts and hemoglobin.

Anemia, caused by insufficient red blood cell production, results in tissues and organs not receiving enough oxygen. This manifests as relentless fatigue, breathlessness from simple tasks, and persistent brain fog. Furthermore, the drug appeared to trigger a harmful trade-off for bone health. Calcium was pulled from its storage in the liver, and while blood calcium levels rose slightly, this pattern suggests the body was breaking down bone to maintain necessary blood calcium levels, a process that could weaken the skeleton over time.

The rats' immune systems also appeared to respond, with elevated white blood cell counts, potentially indicating an inflammatory response. This could occur because reducing stomach acid, the drug's intended effect, might allow more bacteria to survive and migrate, thus putting the immune system on alert. While this research was conducted on rats, the fundamental biology of mineral absorption is similar to humans, making these findings highly relevant.

Prilosec is among the top 10 most prescribed medications in the US, with over 45 million prescriptions annually. The researchers stressed that long-term use is appropriate only for specific diagnoses like Barrett's esophagus. For other users, indefinite use compounds risks. Even when long-term treatment is warranted, patients should undergo regular blood work to detect issues like anemia or low mineral levels early, before symptoms develop. These results reinforce existing warnings from other studies linking long-term use of acid-blocking drugs to anemia, bone fractures, magnesium deficiency, and kidney issues.